INVA

NASDAQ 已收盘

Innoviva

18.41 USD
▲+0.01+0.05%
盘后 18.68 +1.47%
2026-11-19
市值
$1.31B
市盈率
7.24
EPS
2.54
股息率
—
52 周区间
18.19 – 25.15
成交量
839.63K
Beta
0.37
目标价
33.83
52W 低 18.1952W 高 25.15
价格走势

公司简介

Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol, and an inhaled corticosteroid, and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, and ABA, VI. The company also markets GIAPREZA for increasing blood pressure in adults with septic or other distributive shock; XACDURO, a co-packaged for intravenous use ...

关联新闻